http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006275422-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_886928618fafdf5f3c777663fe259898 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 |
filingDate | 2005-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84a44baaf9de23f0cc882d89d085929a |
publicationDate | 2006-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2006275422-A1 |
titleOfInvention | Composition and therapeutic uses thereof |
abstract | A physiologically ingestible with microstructured water having an increased pH compared to unstructured water is used. The composition may further include dissolved oxygen, which may be present in an amount of 20 ppm to 150 ppm. The physiologically ingestible composition may be administered to reduce the amount of lactic acid/lactate produced in the muscle of a mammal undergoing stress. |
priorityDate | 2005-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 129.